-
-
-
-
-
-
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2025
-
-
-
-
-
-
-
BofA Securities Double Downgrades Lyell Immunopharma (LYEL) to Underperform
-
-
-
-
-
-
-
Lyell Immunopharma Announces the Appointment of Rahsaan Thompson as Chief Legal Officer
1,154,866 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

